Biodegradable microspheres for vitreoretinal drug delivery.

Vitreoretinal disorders are one of the major causes of blindness in the developed world. Treatments of these pathologies often include repeated intravitreous injections to achieve intraocular drug levels within the therapeutical range. However, the risks of complications increase with the frequency of intravitreous injections. Controlled drug delivery formulations, offer an excellent alternative to multiple administrations. These systems are capable of delivering drugs over longer time periods than conventional formulations. Currently, several kinds of polymer devices for drug delivery to the posterior segment of the eye are under clinical use, or under investigation. Among these devices, microparticulates, such as microspheres, provide an alternative to multiple injections to obtain sustained release of the drug with a single administration. Among the polymers used to make the injectable microparticles, the most commonly used are poly(lactic acid), poly(glycolic acid) and copolymers of lactic and glycolic acids because they are biocompatible and degrade to metabolic products that are easily eliminated from the body. This article reviews the literature of biodegradable polymeric microspheres loaded with drugs, that have been investigated for delivery by intravitreous injection to treat diverse vitreoretinal diseases.

[1]  Y. Ogura,et al.  Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium. , 1995, Survey of ophthalmology.

[2]  P. A. Pearson,et al.  Dexamethasone sustained drug delivery implant for the treatment of severe uveitis. , 2000, Retina.

[3]  V. Shah,et al.  Statistical Assessment of Mean Differences between Two Dissolution Data Sets* , 1996 .

[4]  J P Benoit,et al.  Formulation of BCNU-loaded microspheres: influence of drug stability and solubility on the design of the microencapsulation procedure. , 1996, Journal of microencapsulation.

[5]  P. Giunchedi,et al.  Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro/in vivo evaluation , 1997 .

[6]  S. Whitcup,et al.  New developments in sustained release drug delivery for the treatment of intraocular disease , 1999, The British journal of ophthalmology.

[7]  D. D’Amico,et al.  Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. , 1992, Archives of ophthalmology.

[8]  G E Visscher,et al.  Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. , 1985, Journal of biomedical materials research.

[9]  C. Doyle Advances in biomaterials: Lee SM editor 1987 Volume 1. Lancaster, PA: Technomics Inc. 286pp. $65 , 1987 .

[10]  R. Jalil,et al.  Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. , 1990, Journal of microencapsulation.

[11]  Y. Ikada,et al.  Lactic acid oligomer microspheres containing hydrophilic drugs. , 1990, Journal of pharmaceutical sciences.

[12]  Y. Ikada,et al.  Feasibility of drug targeting to the retinal pigment epithelium with biodegradable microspheres. , 1994, Current eye research.

[13]  M. Refojo,et al.  Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres. , 1995, Current eye research.

[14]  Sumie Yoshioka,et al.  Preparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate , 1991 .

[15]  H F Edelhauser,et al.  Drug delivery for posterior segment eye disease. , 2000, Investigative ophthalmology & visual science.

[16]  J. Bartlett,et al.  Cytomegalovirus retinitis and acquired immunodeficiency syndrome. , 1989, Archives of ophthalmology.

[17]  I. Grierson,et al.  Biomaterials used in the posterior segment of the eye. , 2000, Biomaterials.

[18]  P. Sansdrap,et al.  Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres. , 1998, Journal of microencapsulation.

[19]  Andreas Zimmer,et al.  Microspheres and nanoparticles used in ocular delivery systems , 1995 .

[20]  Y. Ikada,et al.  Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. , 1988, Journal of biomedical materials research.

[21]  Suming Li,et al.  Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. , 1999 .

[22]  Y. Ikada,et al.  Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. , 1991, Investigative ophthalmology & visual science.

[23]  M. Refojo,et al.  VITREOUS SUBSTITUTE: Experimental Studies and Review , 1984, Retina.

[24]  Suming Li,et al.  Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.

[25]  Y. Ikada,et al.  Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres. , 1999, Investigative ophthalmology & visual science.

[26]  R. Bodmeier,et al.  Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method , 1988 .

[27]  G. Holland,et al.  Rhegmatogenous retinal detachments in patients with AIDS and necrotizing retinal infections. , 1991, Ophthalmology (Rochester, Minn.).

[28]  D. Lewis,et al.  Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive. , 1983, Biology of reproduction.

[29]  Y. Ikada,et al.  Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy. , 1992, Investigative ophthalmology & visual science.

[30]  Robert Gurny,et al.  Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .

[31]  A. Bill,et al.  Drainage of microspheres and RBCs from the vitreous of aphakic and phakic eyes. , 1979, Archives of ophthalmology.

[32]  B. Tighe,et al.  Polymers for biodegradable medical devices. VIII. Hydroxybutyrate-hydroxyvalerate copolymers: physical and degradative properties of blends with polycaprolactone. , 1992, Biomaterials.

[33]  J M Brady,et al.  Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. , 1977, Journal of biomedical materials research.

[34]  J. Mcginity,et al.  Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique. , 1992, Journal of microencapsulation.

[35]  Y. Ikada,et al.  In vitro phagocytosis of polylactide microspheres by retinal pigment epithelial cells and intracellular drug release. , 1994, Current eye research.

[36]  R. Herrero-Vanrell,et al.  Biodegradable poly(DL-lactic-co-glycolic acid) microspheres containing tetracaine hydrochloride. In-vitro release profile. , 1999, Journal of microencapsulation.

[37]  A. Mitra,et al.  Kinetics of a Model Nucleoside (Guanosine) Release from Biodegradable Poly(dl-lactide-co-glycolide) Microspheres: A Delivery System for Long-Term Intraocular Delivery , 2000, Pharmaceutical development and technology.

[38]  M. Refojo,et al.  Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. , 1993, Investigative ophthalmology & visual science.

[39]  H. Balfour,et al.  Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. , 1987, American journal of ophthalmology.

[40]  A. Delgado,et al.  Degradation of DL-PLA-methadone microspheres during in vitro release , 1996 .

[41]  Y. Ikada,et al.  Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits. , 1997, Current eye research.

[42]  M. R. Aberturas,et al.  Optimized preparation of poly d,l (lactic-glycolic) microspheres and nanoparticles for oral administration , 1996 .

[43]  J. Pastor,et al.  Proliferative vitreoretinopathy: an overview. , 1998, Survey of ophthalmology.

[44]  H. Okada,et al.  Biodegradable microspheres in drug delivery. , 1995, Critical reviews in therapeutic drug carrier systems.

[45]  A. Joshi Microparticulates for ophthalmic drug delivery. , 1994, Journal of ocular pharmacology.

[46]  M. Vert,et al.  The use of additives to modulate the release of a sparingly water soluble drug entrapped in PLA50 microparticles: in vivo investigation. , 2000, Journal of microencapsulation.

[47]  M. Refojo,et al.  Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. , 1997, Investigative ophthalmology & visual science.

[48]  A. Mitra,et al.  Ophthalmic Drug Delivery Systems , 2003 .

[49]  R. Cuthbertson,et al.  Intraocular pharmacokinetics and safety of a humanized monoclonal antibody in rabbits after intravitreal administration of a solution or a PLGA microsphere formulation. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[50]  D. Chang,et al.  Phase II results of an intraocular steroid delivery system for cataract surgery. , 1999, Ophthalmology.